SLC40A1 and ovarian carcinoma: Wu et al. reported that miR-194-5p inhibits the expression of FPN, which is positively correlated with hephaestin and the homeostatic iron regulator (HFE), thereby inducing cisplatin resistance in ovarian cancer cells [195].